{"id":1361,"date":"2026-04-15T15:00:00","date_gmt":"2026-04-15T15:00:00","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?p=1361"},"modified":"2026-09-07T18:50:26","modified_gmt":"2026-09-07T18:50:26","slug":"thymosin-alpha-1-immune-peptide-research-guide","status":"publish","type":"post","link":"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/","title":{"rendered":"Thymosin Alpha-1: Immune Peptide Research, Mechanisms &#038; Preclinical Findings"},"content":{"rendered":"<div class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-light-blue ez-toc-container-direction\" id=\"ez-toc-container\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a aria-label=\"Toggle Table of Content\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" href=\"#\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg class=\"list-377408\" fill=\"none\" height=\"20px\" style=\"fill: #999;color:#999\" viewbox=\"0 0 24 24\" width=\"20px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg baseprofile=\"tiny\" class=\"arrow-unsorted-368013\" height=\"10px\" style=\"fill: #999;color:#999\" version=\"1.2\" viewbox=\"0 0 24 24\" width=\"10px\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"><\/path><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class=\"ez-toc-list ez-toc-list-level-1\"><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Chemical_Identity\">Chemical Identity<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Discovery_Story\">Discovery Story<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Mechanism_of_Action\">Mechanism of Action<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Cytokine_Profile\">Cytokine Profile<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Zadaxin_The_Regulatory_Story\">Zadaxin: The Regulatory Story<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Preclinical_Data\">Preclinical Data<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Not_TB-500_Dont_Confuse_Them\">Not TB-500. Don\u2019t Confuse Them.<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Safety_Profile\">Safety Profile<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Where_It_Stands_Legally\">Where It Stands Legally<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Research_Availability\">Research Availability<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#Conclusion\">Conclusion<\/a><\/li><li class=\"ez-toc-page-1 ez-toc-heading-level-2\"><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/lotilabs.com\/resources\/thymosin-alpha-1-immune-peptide-research-guide\/#References\">References<\/a><\/li><\/ul><\/nav><\/div>\n\n<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n<p>35+ countries have approved it. The FDA gave it orphan drug status for four separate indications. It\u2019s been studied continuously since 1977. And most Western researchers couldn\u2019t pick it out of a lineup.<\/p>\n<p><a href=\"https:\/\/lotilabs.com\/product\/thymosin-alpha-1-10mg\/\">Thymosin Alpha-1<\/a> : T\u03b11. 28 amino acids from the thymus gland. It fires up TLR2 and TLR9 simultaneously, matures dendritic cells, pushes T-cell differentiation, and supercharges NK cell killing. The synthetic version goes by thymalfasin (brand name Zadaxin), and it\u2019s been deployed against hepatitis B and C across Asia for years. In America? Investigational. Go figure.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Chemical_Identity\"><\/span><span class=\"ez-toc-section\" id=\"Chemical_Identity\"><\/span>Chemical Identity<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Twenty-eight residues. Acetylated serine at the N-terminus. Derived from prothymosin alpha : a larger 109-amino acid precursor that thymic epithelial cells chop up and release into circulation.<\/p>\n<ul>\n<li><strong>Sequence:<\/strong> Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN<\/li>\n<li><strong>Molecular Formula:<\/strong> C\u2081\u2082\u2089H\u2082\u2081\u2085N\u2083\u2083O\u2085\u2085<\/li>\n<li><strong>Molecular Weight:<\/strong> 3,108.3 g\/mol<\/li>\n<li><strong>CAS:<\/strong> 62304-98-7<\/li>\n<\/ul>\n<p>Heavily acidic : loaded with aspartate and glutamate residues. Net negative charge at physiological pH. Same family name. Entirely different biology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Discovery_Story\"><\/span><span class=\"ez-toc-section\" id=\"Discovery_Story\"><\/span>Discovery Story<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>1960s. Allan Goldstein and Abraham White at Albert Einstein College of Medicine. They\u2019re studying why the thymus gland matters for immune development.<\/p>\n<p>Ten years of purification work later, 1977: they pull out one specific 28-amino acid peptide from that fraction. Thymosin alpha-1. First individual peptide isolated from the thymic mixture that kept its immunological punch. The sequence got mapped. Production in rat thymus was confirmed (Hannappel &amp; Huff, 1984; Proc Natl Acad Sci USA 81:1008-1011).<\/p>\n<p>SciClone Pharmaceuticals later synthesized it as thymalfasin (Zadaxin) : identical amino acid sequence to the natural peptide. That synthetic version became the basis for regulatory filings across 35+ countries. From crude thymic extract to a defined, synthesized compound with international approvals. Took about three decades.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span><span class=\"ez-toc-section\" id=\"Mechanism_of_Action\"><\/span>Mechanism of Action<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Not a one-trick peptide. Multiple receptor targets. Multiple cell types.<\/p>\n<h3>TLR2 + TLR9: Both At Once<\/h3>\n<p>Most immune compounds hit one receptor. T\u03b11 hits two Toll-like receptors on myeloid and dendritic cells.<\/p>\n<p>Through TLR9: MyD88 cascade fires. IRF-7 gets activated. Cells pump out IFN-\u03b1 : type I interferon. First-line antiviral defense. Through TLR2: NF-\u03baB translocates to the nucleus. Now you\u2019re getting IL-12, TNF-\u03b1, IL-6. Phagocytes wake up. Microbial recognition gets cranked.<\/p>\n<p>The two arms amplify each other. TLR9\u2019s IFN-\u03b1 boosts the scale of TLR2-driven responses. Coordinated, not additive (Romani et al., 2006; Blood 108(7):2265-2274).<\/p>\n<h3>Dendritic Cells: From Immature to Armed<\/h3>\n<p>T\u03b11 matures dendritic cells. MHC class I and II go up. Co-stimulatory molecules (CD80\/CD86) come online. Antigen processing capacity ramps.<\/p>\n<p>But it\u2019s not just activation. T\u03b11 also flips on IDO : indoleamine 2,3-dioxygenase : in DCs. That\u2019s tryptophan catabolism. Creates a regulatory environment. Gas pedal and brake at the same time.<\/p>\n<h3>T Cells: The Core Function<\/h3>\n<p>Classic T\u03b11 territory. Thymic progenitors \u2192 functional CD4+ helpers and CD8+ killers. The two pillars of cellular immunity. But there\u2019s more:<\/p>\n<ul>\n<li>Tilts Th1\/Th2 toward Th1 : cell-mediated over antibody-driven. Th17 and Treg populations also shift<\/li>\n<li>Immunocompromised animals: T-cell counts partially restored. Rosette percentages climb<\/li>\n\n<\/ul>\n<h3>NK Cells<\/h3>\n<p>T\u03b11 activates their killing capacity directly : activating receptors get upregulated, IFN-\u03b3 production spikes, and there\u2019s synergy with IL-2 for proliferation.<\/p>\n<p>Different immunomodulatory angle: <a href=\"https:\/\/lotilabs.com\/resources\/kpv-peptide-top-benefits-and-uses-for-gut-health-and-inflammation\/\">KPV peptide<\/a> works through alpha-MSH receptors instead.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Cytokine_Profile\"><\/span><span class=\"ez-toc-section\" id=\"Cytokine_Profile\"><\/span>Cytokine Profile<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<table>\n<thead>\n<tr><th>Cytokine<\/th><th>Direction<\/th><th>How<\/th><th>What It Means<\/th><\/tr>\n<\/thead>\n<tbody>\n<tr><td>IFN-\u03b1<\/td><td>\u2191<\/td><td>TLR9 \u2192 IRF-7<\/td><td>Antiviral innate response<\/td><\/tr>\n<tr><td>IFN-\u03b3<\/td><td>\u2191<\/td><td>NK and T-cell activation<\/td><\/tr>\n<tr><td>IL-2<\/td><td>\u2191<\/td><td>T-cell cascade<\/td><td>T-cell proliferation<\/td><\/tr>\n<tr><td>IL-10<\/td><td>\u2191<\/td><td>Treg and DC modulation<\/td><\/tr>\n<tr><td>IL-12<\/td><td>\u2191<\/td><td>TLR2 \u2192 NF-\u03baB<\/td><\/tr>\n<tr><td>IL-1\u03b2<\/td><td>\u2193<\/td><td>Inflammasome regulation<\/td><\/tr>\n<tr><td>TNF-\u03b1<\/td><td>\u2193<\/td><\/tr>\n<\/tbody>\n<\/table>\n<p>Protective cytokines go up. Damage cytokines come down. IL-10 : tolerance : also rises. It\u2019s an unusually balanced profile. Most immune compounds tilt one direction. That\u2019s rare.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Zadaxin_The_Regulatory_Story\"><\/span><span class=\"ez-toc-section\" id=\"Zadaxin_The_Regulatory_Story\"><\/span>Zadaxin: The Regulatory Story<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Here\u2019s where it stands:<\/p>\n<ul>\n\n<li>Phase II completed for hep B, Phase III for hep C in the US<\/li>\n<li>Not approved in the US (beyond orphan designation), Japan, or most of Europe. Italy is the notable exception<\/li>\n<\/ul>\n<p>Regulatory status varies enormously by country. In the US and EU, T\u03b11 remains investigational.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Preclinical_Data\"><\/span><span class=\"ez-toc-section\" id=\"Preclinical_Data\"><\/span>Preclinical Data<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3>Hepatitis B<\/h3>\n<p>Multiple research groups have examined thymalfasin in HBV models : Chien et al. (1998), Mutchnick et al. (1999), Zavaglia et al. (2000) : with varying designs and endpoint measurements.<\/p>\n<h3>Fungal Infections<\/h3>\n<p>TLR2 is a primary receptor for fungal cell wall components. That makes T\u03b11\u2019s TLR2 agonism directly relevant.<\/p>\n\n<p>It\u2019s been studied as an adjunctive agent during immunosuppressive treatment.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Not_TB-500_Dont_Confuse_Them\"><\/span><span class=\"ez-toc-section\" id=\"Not_TB-500_Dont_Confuse_Them\"><\/span>Not TB-500. Don\u2019t Confuse Them.<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>\u201cThymosin\u201d is in both names. That\u2019s where the overlap stops.<\/p>\n<p>T\u03b11: 28 amino acids, 3,108 g\/mol.<\/p>\n<p>TB-500 (thymosin beta-4): 43 amino acids, 4,921 g\/mol.<\/p>\n<p>Same family. Completely different biology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Safety_Profile\"><\/span><span class=\"ez-toc-section\" id=\"Safety_Profile\"><\/span>Safety Profile<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Favorable across preclinical studies. Key points:<\/p>\n<ul>\n<li>Minimal adverse findings at standard research concentrations in animal models<\/li>\n<li>Thymalfasin studied at 1.6 mg subcutaneous in investigational protocols<\/li>\n<li>Anti-apoptotic: T\u03b11 antagonizes dexamethasone-induced thymocyte death in a time- and concentration-dependent manner (Baumann et al., 2000; Int J Immunopharmacol 22(12):1057-1066)<\/li>\n<li>Standard peptide storage requirements : temperature and handling matter for bioactivity<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Where_It_Stands_Legally\"><\/span><span class=\"ez-toc-section\" id=\"Where_It_Stands_Legally\"><\/span>Where It Stands Legally<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Approved in Asia and parts of Europe. FDA orphan designation but no US approval. Investigational in Japan and most Western countries except Italy. For research use : verify your jurisdiction\u2019s rules.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Research_Availability\"><\/span><span class=\"ez-toc-section\" id=\"Research_Availability\"><\/span>Research Availability<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>From Loti Labs:<\/p>\n<ul>\n<li><a href=\"https:\/\/lotilabs.com\/product\/thymosin-alpha-1-10mg\/\">Thymosin Alpha-1 10mg<\/a> : $79.99<\/li>\n\n<\/ul>\n\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Forty-plus years of data. Approvals on three continents.<\/p>\n<p>For a peptide that\u2019s been studied since 1977 and is still generating new mechanistic insights, T\u03b11 has staying power that most research compounds don\u2019t.<\/p>\n<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"References\"><\/span><span class=\"ez-toc-section\" id=\"References\"><\/span>References<span class=\"ez-toc-section-end\"><\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ol>\n<li>Goldstein AL. History of the discovery of the thymosins. <em>Ann N Y Acad Sci.<\/em> 2007;1112:1-13. PMID: 17468229<\/li>\n<li>Romani L, et al. Thymosin alpha 1 activates dendritic cell tryptophan catabolism. <em>Blood.<\/em> 2006;108(7):2265-2274. PMID: 16740584<\/li>\n<li>Hannappel E, Huff T. Thymosins: prothymosin alpha, parathymosin, and beta-thymosins. <em>Vitam Horm.<\/em> 2003;66:257-296. PMID: 12852258<\/li>\n<li>Baumann CA, et al. T\u03b11 antagonizes dexamethasone-induced apoptosis of murine thymocytes. <em>Int J Immunopharmacol.<\/em> 2000;22(12):1057-1066. PMID: 11137614<\/li>\n<li>Garaci E, et al. <em>Expert Opin Biol Ther.<\/em> 2015;15(Suppl 1):S31-S39. PMID: 26096835<\/li>\n<li>Costantini C, et al. Reappraisal of thymosin alpha 1 in cancer research. <em>Front Oncol.<\/em> 2019;9:873. PMID: 31572680<\/li>\n<li>Billich A. Thymosin alpha 1 : SciClone Pharmaceuticals. <em>Curr Opin Investig Drugs.<\/em> 2002;3(5):698-707. PMID: 12090542<\/li>\n<li>Armutcu F, et al. T\u03b11 attenuates lipid peroxidation in fructose-induced steatohepatitis. <em>Clin Biochem.<\/em> 2005;38(6):540-547.<\/li>\n<li>Yang X, et al. Effect of T\u03b11 on Th1, Th2, Th17, and Treg subpopulations in vitro. <em>Braz J Med Biol Res.<\/em> 2012;45(1):25-32.<\/li>\n<li>Giuliani C, et al. T\u03b11 regulates MHC class I expression at transcriptional level. <em>Eur J Immunol.<\/em> 2000;30(3):778-786.<\/li>\n<li>FDA. Thymosin Alpha-1 Related Bulk Drug Substances. <em>Office of Pharmaceutical Quality Assessment II.<\/em> 2024.<\/li>\n<li>Chien RN, et al. <em>Hepatology.<\/em> 1998;27(5):1383-1387. PMID: 9581696<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Research guide on Thymosin Alpha-1, approved in 35+ countries with FDA orphan drug status. Covers dendritic cell maturation, T-cell activation, TLR signaling, and immunomodulatory mechanisms.<\/p>\n","protected":false},"author":1,"featured_media":1388,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1361","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=1361"}],"version-history":[{"count":0,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1361\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media\/1388"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=1361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/categories?post=1361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/tags?post=1361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}